The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGVP.L Regulatory News (GVP)

  • There is currently no data for GVP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Letter to Associated Capital Group, Inc.

15 Oct 2020 17:46

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

PR Newswire

London, October 15

Metage Capital Limited: open letter to Associated Capital Group, Inc.

Mr Bruce LismanAssociated Capital Group, Inc.191 Mason StreetGreenwich, CT 06830

For Immediate Release

15th October 2020

Dear Mr Lisman,

Re: respecting the vote by shareholders to discontinue the Gabelli Value Plus+ Trust Plc. (“GVP”)

On 6th October 2020 you held a webinar setting out the position of Associated Capital Group, Inc. (“ACG”) on the continuation of GVP. When signing up to this webinar, investors were asked to submit questions, however none were addressed. We have been dissatisfied by the subsequent response from ACG to the questions that we asked and believe that other shareholders would share similar queries. We therefore ask you to respond publicly to the following:

1. In the GVP announcement of 6th October, the Board of GVP refers to “…a letter received by the Board from the general counsel to ACG on 2 October 2020 indicating that (unspecified) litigation concerning the company may be a distinct possibility…” Can you please explain why ACG is threatening legal action, what potential illegality or breach of contract you perceive and what the aim of this litigation would be?

2. The “Magna Carta of shareholder Rights” on Gabelli Investors, Inc.’s website[1] states that it is in favour of “one share: one vote” and that “…we will vote against…supermajority voting…” How is attempting to frustrate the will of a clear majority of shareholders consistent with Gabelli’s corporate governance principles?

3. The Board has offered the potential of an in specie redemption of ACG’s pro rata share of the GVP portfolio or the ability to provide ACG with a roll over vehicle with a similar strategy and manager. This would enable ACG to continue its investment without frustrating the desire of other shareholders for a cash exit. How would you justify attempting to trap the majority of shareholders against their will?

Finally we would like to thank the Board of GVP for their steadfastness in a difficult situation, which is an excellent demonstration of the highest standards of corporate governance in London-listed investment trusts.

Yours faithfully,Tom Sharp, DirectorMetage Capital LimitedPrinces House, 38 Jermyn Street, London SW1Y 6DN, United KingdomEmail: tom.sharp@metage.comTel: +(44) 203 813 8590

[1] https://www.gabelli.co.uk/wp-content/uploads/2015/01/magnacarta092403.pdf

Date   Source Headline
7th Oct 20209:24 amRNSNet Asset Value(s)
6th Oct 20209:48 amRNSNet Asset Value(s)
6th Oct 20207:00 amRNSUpdate on Proposals for Future of the Company
5th Oct 20201:22 pmRNSListing Rule 15.6.8
5th Oct 20209:05 amRNSNet Asset Value(s)
2nd Oct 20209:40 amRNSNet Asset Value(s)
1st Oct 20209:20 amRNSNet Asset Value(s)
30th Sep 20209:37 amRNSNet Asset Value(s)
29th Sep 20209:43 amRNSNet Asset Value(s)
28th Sep 202012:31 pmRNSHolding(s) in Company
28th Sep 20209:00 amRNSNet Asset Value(s)
25th Sep 202010:38 amRNSNet Asset Value(s)
24th Sep 202010:13 amRNSNet Asset Value(s)
23rd Sep 20209:16 amRNSNet Asset Value(s)
22nd Sep 20204:33 pmRNSHolding(s) in Company
22nd Sep 20209:00 amRNSNet Asset Value(s)
21st Sep 20209:00 amRNSNet Asset Value(s)
18th Sep 20209:56 amRNSHolding(s) in Company
18th Sep 20209:45 amRNSNet Asset Value(s)
17th Sep 20209:00 amRNSNet Asset Value(s)
16th Sep 20209:43 amRNSNet Asset Value(s)
15th Sep 20205:15 pmRNSUpdate on Proposals for the Future of the Company
15th Sep 20209:04 amRNSNet Asset Value(s)
14th Sep 20209:00 amRNSNet Asset Value(s)
11th Sep 20209:00 amRNSNet Asset Value(s)
10th Sep 20209:00 amRNSNet Asset Value(s)
9th Sep 20209:00 amRNSNet Asset Value(s)
8th Sep 20209:00 amRNSNet Asset Value(s)
7th Sep 20209:38 amRNSNet Asset Value(s)
4th Sep 202011:30 amRNSNet Asset Value(s)
3rd Sep 20209:00 amRNSNet Asset Value(s)
2nd Sep 20202:33 pmRNSNet Asset Value(s)
1st Sep 20209:03 amRNSNet Asset Value(s)
28th Aug 202010:04 amRNSNet Asset Value(s)
27th Aug 202010:24 amRNSNet Asset Value(s)
26th Aug 20209:11 amRNSNet Asset Value(s)
25th Aug 20209:39 amRNSNet Asset Value(s)
24th Aug 20209:31 amRNSNet Asset Value(s)
21st Aug 20209:57 amRNSNet Asset Value(s)
20th Aug 202010:20 amRNSNet Asset Value(s)
19th Aug 202011:06 amRNSHolding(s) in Company
19th Aug 20209:00 amRNSNet Asset Value(s)
18th Aug 202010:13 amRNSNet Asset Value(s)
17th Aug 20209:16 amRNSNet Asset Value(s)
14th Aug 202011:24 amRNSNet Asset Value(s)
13th Aug 20209:00 amRNSNet Asset Value(s)
12th Aug 20201:06 pmRNSHolding(s) in Company
12th Aug 20209:00 amRNSNet Asset Value(s)
11th Aug 20209:00 amRNSNet Asset Value(s)
10th Aug 20209:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.